
CMI · NYSE
Consensus is Buy across all 16 tracked analysts, with a mean price target of $757.50 versus the latest close of $635.96. The supplied data provide no low or high target, so the width of the target spread and the identities of the most and least bullish analysts cannot be established. No firm-specific rating changes or target revisions were reported during the week. The substantive disagreement visible in the evidence is between the positive revenue surprise and year-over-year profit increase on one side, and the 5.32% earnings miss plus the decline in full-year 2025 net income from 2024 on the other. Individual analyst reasoning is not supplied.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| UBS | — | $626 | -0.8% | Jun 8, 2026 | Open the report this row came from |